Cargando…
Performance differences among commercially available antigen rapid tests for COVID-19 in Brazil
A rapid and accurate diagnosis is a crucial strategy for containing the coronavirus disease (COVID-19) pandemic. Considering the obstacles to upscaling the use of RT–qPCR, rapid tests based on antigen detection (Ag-RDT) have become an alternative to enhance mass testing, reducing the time for a prom...
Autores principales: | Freire, Mariana Lourenço, Alves, Lindicy Leidicy, de Souza, Carolina Senra, Saliba, Juliana Wilke, Faria, Verônica, Pedras, Mariana Junqueira, Carvalho, Nara de Oliveira, Andrade, Gláucia Queiroz, Rabello, Ana, Avelar, Daniel Moreira, Cota, Gláucia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9202877/ https://www.ncbi.nlm.nih.gov/pubmed/35709075 http://dx.doi.org/10.1371/journal.pone.0269997 |
Ejemplares similares
-
Diagnostic performance of commercially available COVID-19 serology tests in Brazil
por: Cota, Gláucia, et al.
Publicado: (2020) -
The cure rate after different treatments for mucosal leishmaniasis in the Americas: A systematic review
por: Carvalho, Janaína de Pina, et al.
Publicado: (2022) -
Evaluation of a new brand of immunochromatographic test for visceral leishmaniasis in Brazil made available from 2018
por: Freire, Mariana Lourenço, et al.
Publicado: (2018) -
Performance of serological tests available in Brazil for the diagnosis of human visceral leishmaniasis
por: Freire, Mariana Lourenço, et al.
Publicado: (2019) -
Development and initial validation of a cutaneous leishmaniasis impact questionnaire
por: Galvão, Endi Lanza, et al.
Publicado: (2018)